Thomas Bures
Director of Finance/CFO en PIERIS PHARMACEUTICALS, INC. .
Fortuna: 3 527 $ al 31/03/2024
Perfil
Thomas Bures is currently the Senior VP, Chief Financial & Accounting Officer at Pieris Pharmaceuticals, Inc. He previously worked as the Vice President & Assistant Controller at PAREXEL International Corp.
and as the Vice President & Controller at Genocea Biosciences, Inc. He obtained his undergraduate degree from the College of the Holy Cross (Massachusetts).
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 19/04/2023 | 19 273 ( 0.02% ) | 3 527 $ | 31/03/2024 |
Cargos activos de Thomas Bures
| Empresas | Cargo | Inicio |
|---|---|---|
| PIERIS PHARMACEUTICALS, INC. | Director of Finance/CFO | 13/09/2019 |
Antiguos cargos conocidos de Thomas Bures.
| Empresas | Cargo | Fin |
|---|---|---|
| GENOCEA BIOSCIENCES, INC. | Comptroller/Controller/Auditor | 01/12/2017 |
| PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | - |
Formación de Thomas Bures.
| College of the Holy Cross (Massachusetts) | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| GENOCEA BIOSCIENCES, INC. | Health Technology |
| PIERIS PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
PAREXEL International Corp.
 PAREXEL International Corp. Miscellaneous Commercial ServicesCommercial Services PAREXEL International Corp. provides biopharmaceutical services. It offers clinical research and logistics, medical communications, consulting, commercialization and advanced technology products and services for pharmaceutical, biotechnology and medical device industries. The company was founded in 1983 and is headquartered in Newton, MA. | Commercial Services |
- Bolsa de valores
- Insiders
- Thomas Bures
